Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

Launched by ALLEGHENY SINGER RESEARCH INSTITUTE (ALSO KNOWN AS ALLEGHENY HEALTH NETWORK RESEARCH INSTITUTE) · Feb 27, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how a combination of resistance training (a type of exercise that helps build strength) and a high-quality protein nutrition plan can improve body composition and overall fitness in women undergoing treatment for breast cancer. Specifically, it aims to see if following this exercise and nutrition plan during neoadjuvant chemotherapy (which is chemotherapy given before surgery) can help women feel stronger and healthier.

To participate in this trial, women aged 20 to 89 who have been diagnosed with invasive breast cancer and are planning to start chemotherapy can apply. Participants will engage in group exercise sessions and receive guidance on nutrition. However, those with certain health conditions that might make it unsafe to participate in exercise or who have allergies to specific proteins will not be eligible. This study is currently recruiting participants and aims to provide valuable insights into supporting women’s health during cancer treatment.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 20-89 years
• • 2. Women with a biopsy proven diagnosis of invasive carcinoma of the breast.
• • 3. Women must undergo neoadjuvant chemotherapy for breast cancer treatment prior to surgery
• • 4. Must be able to read and understand English and consent for themselves.
• Exclusion Criteria:
• • 1. Inability to get up and down off the ground or squat body weight
• • 2. Inability to safely engage in group exercise sessions as deemed by study PI
• • 3. Severe arthritic, joint, cardiovascular, musculoskeletal, or any other condition deemed by PI to be unsafe to engage in resistance training
• • 4. Lactose intolerance
• • 5. Cow's milk or whey protein allergy
• • 6. Pregnant women
• • 7. Males